Why the Katalin Karikó mRNA story opens the series
Katalin Karikó spent three decades being told her idea would not work, and the Katalin Karikó mRNA research that followed changed medicine. The episode follows that argument rather than the eventual prize, because the interesting question is how a researcher keeps a programme alive with no grant, no lab of her own and no obvious ally.
Because the dossier draws on patents, grant refusals and laboratory correspondence, the narrative can show exactly where the funding stopped and who kept the work moving. For example, the 1990s patent trail records a series of small institutional bets that larger funders had already declined.
In addition, the episode places Katalin Karikó inside the wider roster of women whose work was absorbed before it was credited. As a result, the screening series starts with a question the master story roster keeps asking: who gets to be remembered as the discoverer?
The scientific record behind this dossier is documented in the 2023 Nobel Prize citation, which credits Katalin Karikó alongside Drew Weissman for the nucleoside base modifications that made mRNA vaccines possible.
What Katalin Karikó changed
Katalin Karikó changed how a field treats its outsiders, and the episode keeps that argument in view from the first minute.